Neogen (NEOG) vs UFP Technologies (UFPT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Neogen (NEOG) has outperformed UFP Technologies (UFPT) over the past year, gaining 101.2% versus a gain of 45.9%. Over five years, UFPT leads with a +349.0% price change compared with -71.5% for NEOG. Neogen is the larger company by market cap ($2.61 billion vs $2.25 billion), about 1.2 times the size, while UFP Technologies is growing revenue faster (+19.5% vs -2.7%).
On valuation, UFP Technologies trades at a lower forward P/E (24.4x vs 31.4x for Neogen). UFP Technologies converts more of its revenue into profit, with a net margin of 11.3% versus -0.9%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | NEOG | UFPT |
|---|---|---|
| Share price | $11.94 | $290.06 |
| Market cap | $2.61B | $2.25B |
| 1-day change | +1.92% | +1.22% |
| YTD return | +67.53% | +29.06% |
| 1-year return | +101.20% | +45.90% |
| 5-year return | -71.47% | +349.01% |
| P/E ratio (TTM) | — | 31.32 |
| Forward P/E | 31.41 | 24.43 |
| EPS (TTM) | $-0.26 | $9.26 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $870.40M | $602.80M |
| Revenue growth (YoY) | -2.72% | +19.50% |
| Net income (latest FY) | $-7.90M | $68.31M |
| Gross margin | 46.93% | 28.27% |
| Operating margin | -2.48% | 15.32% |
| Net margin | -0.91% | 11.33% |
| 52-week high | $14.26 | $338.71 |
| 52-week low | $5.37 | $173.86 |
| Distance from 52-week high | -16.30% | -14.36% |
| Analyst consensus | buy | none |
| Avg. price target upside | +17.30% | +22.39% |
| Average volume | 3.14M | 154.12K |
| Shares outstanding | 218.31M | 7.75M |
| Employees | 2,636 | 4,846 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- NEOG has outperformed UFPT by 55.3 percentage points over the past year.
- UFP Technologies is more profitable, keeping 11.3 cents of every revenue dollar as net income versus -0.9 cents for Neogen.
- UFP Technologies grew revenue faster in its latest fiscal year (+19.50% vs -2.72%).
About Neogen
NEOG stock →Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally. It operates through Food Safety and Animal Safety segments.
Health Care · Biotechnology: In Vitro & In Vivo Diagnostic Substances · 2,636 employees
About UFP Technologies
UFPT stock →UFP Technologies, Inc., together with its subsidiaries, designs and manufactures solutions for medical devices, sterile packaging, and other engineered custom products in the United States. The company provides protective drapes for robotic surgery, patient handling and comfort, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, components for cardiac implants, dispenser coils for catheters, and biopharma drug manufacturing.
Health Care · Medical/Dental Instruments · 4,846 employees
NEOG vs UFPT FAQ
Which is bigger, Neogen or UFP Technologies?
Neogen (NEOG) is larger, with a market capitalization of $2.61B compared with $2.25B for UFP Technologies (UFPT).
Which stock has performed better over the past year, NEOG or UFPT?
NEOG returned +101.20% over the past 12 months, compared with +45.90% for UFPT (price return, excluding dividends). Past performance does not predict future results.
Are Neogen and UFP Technologies in the same industry?
Both are in the Health Care sector, but in different industries: Biotechnology: In Vitro & In Vivo Diagnostic Substances for Neogen and Medical/Dental Instruments for UFP Technologies.